PEDIATRICS Vol. 108 No. 2 August 2001, p. e29
Received Jan 24, 2001; accepted Apr 9, 2001.
,
, §,
,
, and
From the Departments of * Pediatrics and Objectives. Despite the prominence of
lead poisoning as a public health problem, recent Government Accounting
Office reports indicate that only one fifth of children who are covered
by Medicaid have been screened for lead poisoning. The purpose of this
study was to examine the lead screening histories of children who were
enrolled in a statewide, Medicaid managed care plan to determine the
relative impact of the type of primary care provider site and family
sociodemographic characteristics on the likelihood of being screened.
The study also examined the prevalence of and risk factors for lead
poisoning of children who had been screened.
Methods. A random sample of 2000 preschool-age children
was chosen from those who were enrolled continuously in the statewide,
expanded, Medicaid managed care program for a 1-year period and between the ages of 19 and 35 months at the end of that year. Sociodemographic characteristics and lists of primary care providers were obtained from
administrative data sets. Medical record audits at primary care
provider sites were performed to obtain the lead screening histories of
the children, including test dates and results.
Results. Data on 1988 children were used for study
analyses, and 80% of these children had at least 1 documented blood
lead level. Children whose primary care provider was an office-based
physician were less likely to be screened as compared with patients of
health centers, hospital-based clinics, and staff model health
maintenance organizations (68%, 86%, 89%, and 91% respectively).
Variation in screening rates persisted in a multivariate analysis
controlling for family sociodemographic characteristics and practice
level variation. Of the 1587 children who had a documented blood lead test, 467 children (29%) had a blood lead level of Conclusions. Blood lead screening rates in Rhode
Island's Medicaid managed care program are dramatically
higher than national estimates for children who are enrolled
in Medicaid. Potential explanations for this finding are 1) a high
sensitization to the problem of lead poisoning in Rhode
Island, 2) the primary care focus of the Medicaid program in
Rhode Island facilitates the delivery of preventive services, and 3)
the medical record audit approach used in this study was more
comprehensive in identifying blood lead screens than techniques used in
national studies. The high prevalence of elevated blood lead levels
found in this study emphasizes the importance of screening among
children who are enrolled in Medicaid.
Community Health and
§ Center for Statistical Sciences, Brown University, Providence, Rhode
Island;
Division of Family Health, State of Rhode Island,
Providence, Rhode Island; and ¶ Department of Human Services, State of
Rhode Island, Cranston, Rhode Island.
10 mg/dL on at
least 1 test.
This article has been cited by other articles:
![]() |
A. N. Feinberg and C. K. Cummings Blood Lead Screening Clinical Pediatrics, September 1, 2005; 44(7): 569 - 574. [Abstract] [PDF] |
||||